444119-02-2

Upstream product

• 69739-34-0 t-butyldimethylsiyl triflate 
• 385422-22-0 3-O-acetyl-2-azido-6-O-benzyl-2-deoxy-1-O-tert-butyldimethylsilyl-β-D-glucopyranoside 
• 108-48-5 2,6-dimethylpyridine 
• 385422-21-9 3-O-acetyl-2-azido-1-O-tert-butyldimethylsilyl-2-deoxy-4,6-O-benzylidene-β-D-glucopyranoside 
• 138923-10-1 2-azido-4,6-O-benzylidene-2-deoxyl-1-O-tert-butyldimethylsilyl-β-D-glucopyranoside 
• 99049-65-7 tert-Butyldimethylsilyl-3,4,6-tri-O-acetyl-2-azido-2-desoxy-β-D-glucopyranosid 
• 171032-74-9 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-D-glucopyranose 
• 99049-67-9 tert-Butyldimethylsilyl-2-azido-2-desoxy-β-D-glucopyranosid 
• 1125-88-8 benzaldehyde dimethyl acetal 

Relevant academic research and scientific papers

Modular synthesis of heparin oligosaccharides

A general, modular strategy for the first completely stereoselective synthesis of defined heparin oligosaccharides is described. Six monosaccharide building blocks (four differentially protected glucosamines, one glucuronic and one iduronic acid) were uti

Solid- and solution-phase synthesis of heparin and other glycosaminoglycans

Described is a modular, general synthetic strategy for the preparation in solution and on a solid support of heparin, heparin-like glycosaminoglycans, glycosaminoglycans and non-natural analogs of each of them. Additionally, the modular strategy provides